PMID: 11327378May 1, 2001

Partial remission phase and metabolic control in type 1 diabetes mellitus in children and adolescents

Journal of Pediatric Endocrinology & Metabolism : JPEM
E BöberA Büyükgebiz

Abstract

A better understanding of the remission phase, while residual beta-cell function is still present in recently diagnosed type 1 (insulin dependent) diabetes mellitus (IDDM), is very important because of the potential for pharmacological intervention to preserve this function. To evaluate the natural course and characteristics of the remission phase in children and adolescents with IDDM, a retrospective study was performed on patients diagnosed with IDDM under the age of 18 years during the years 1991-1998. Sixty-two patients whose medical records were available were included in the study. Data were collected by reviewing the hospital records of patients from the time of diagnosis through the first 24 months after diagnosis. The duration of symptoms and history of infection prior to presentation, diabetic ketoacidosis (DKA) at diagnosis, length of hospitalization, initial glucose level, basal C-peptide levels at diagnosis, daily insulin requirements per kg body weight and HbA1c at diagnosis and at each visit were recorded. Thirty-five patients (56.5%) entered partial remission. We observed similar remission rates in those aged <10 and > or =10 years at diagnosis and in boys and girls. History of infection and presentation with DK...Continue Reading

References

Oct 4, 2011·PloS One·Samuel W CutfieldWayne S Cutfield
Sep 17, 2009·Pediatric Diabetes·Jennifer J Couper, Kim Donaghue
Aug 23, 2007·Clinical and Experimental Immunology·S Glisic-MilosavljevicS Ghosh
Jul 10, 2008·Diabetes/metabolism Research and Reviews·Maria Nordwall, Johnny Ludvigsson
Oct 8, 2011·Diabetic Medicine : a Journal of the British Diabetic Association·S PilacinskiB Wierusz-Wysocka
May 17, 2014·Journal of Theoretical Biology·Majid Jaberi-DourakiAnmar Khadra
Aug 15, 2015·Journal of Theoretical Biology·Majid Jaberi-DourakiAnmar Khadra
Oct 25, 2013·Endocrine Research·Pilar Isabel Beato-Víbora, M Ángeles Tormo-García
Aug 31, 2013·Diabetes Care·Jesper S SørensenDanish Society for Diabetes in Childhood and Adolescence
Aug 16, 2016·Journal of the Formosan Medical Association = Taiwan Yi Zhi·Yi-Chen ChenWen-Yu Tsai
Mar 27, 2004·Pediatric Diabetes·H Peter ChaseMarian Rewers
Mar 8, 2007·Pediatric Diabetes·Jennifer J CouperInternational Society for Pediatric and Adolescent Diabetes
Nov 6, 2007·Nature Reviews. Immunology·Matthias von HerrathKevan Herold
Jun 12, 2012·Archivum Immunologiae Et Therapiae Experimentalis·Agnieszka SzypowskaWłodzimierz Luczyński
Jul 26, 2019·Diabetes/metabolism Research and Reviews·Ting ZhongZhiguang Zhou
Oct 11, 2017·Journal of Pediatric Endocrinology & Metabolism : JPEM·Aleksandra PyziakWojciech Mlynarski
Oct 18, 2014·Pediatric Diabetes·Jennifer J CouperInternational Society for Pediatric and Adolescent Diabetes

Citations

May 1, 1992·Diabetes Research and Clinical Practice·E GuastamacchiaG M Nardelli
Feb 1, 1995·European Journal of Clinical Investigation·R VeijolaJ Iionen
Oct 31, 1998·Diabetic Medicine : a Journal of the British Diabetic Association·R BonfantiE Bonifacio

Related Concepts

C-Peptide
Senility
Novolin
Diabetic Ketoacidosis
Diabetes Mellitus, Insulin-Dependent
Remission Induction
Puberty
Diabetes, Autoimmune
Hb A1a-2
Hospital Stay

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.